ELISA microarray technology as a high-throughput system for cancer biomarker validation

References

• Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845–867 (2002).
   PubMed Web of Science ®Google Scholar
• Wadlow R, Ramaswamy S. DNA microarrays in clinical cancer research. Curr. Mol. Med. 5, 111–120 (2005).
   PubMed Web of Science ®Google Scholar
• Zangar RC, Varnum SM, Bollinger N. Studying cellular processes and detecting disease with protein microarrays. Drug Metab. Rev. 37, 473–487 (2005).
   PubMed Web of Science ®Google Scholar
• Zhou M, Conrads TP, Veenstra TD. Proteomics approaches to biomarker detection. Brief. Funct. Genomic. Proteomic. 4, 69–75 (2005).
   PubMedGoogle Scholar
• Banez LL, Srivastava S, Moul JW. Proteomics in prostate cancer. Curr. Opin. Urol. 15, 151–156 (2005).
   PubMed Web of Science ®Google Scholar
• Umar A, Srivastava S. The promise of biomarkers in colorectal cancer detection. Dis. Markers 20, 87–96 (2004).
   PubMed Web of Science ®Google Scholar
• Schulte I, Tammen H, Selle H, Schulz-Knappe P. Peptides in body fluids and tissues as markers of disease. Expert Rev. Mol. Diagn. 5, 145–157 (2005).
   PubMed Web of Science ®Google Scholar
• Davidsson P, Sjogren M. The use of proteomics in biomarker discovery in neurodegenerative diseases. Dis. Markers 21, 81–92 (2005).
   PubMed Web of Science ®Google Scholar
• Merrick BA, Bruno ME. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity. Curr. Opin. Mol. Ther. 6, 600–607 (2004).
   PubMed Web of Science ®Google Scholar
• Chen R, Pan S, Brentnall TA, Aebersold R. Proteomic profiling of pancreatic cancer for biomarker discovery. Mol. Cell. Proteomics 4, 523–533 (2005).
   PubMed Web of Science ®Google Scholar
• Drake RR, Cazare LH, Semmes OJ, Wadsworth JT. Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers. Expert Rev. Mol. Diagn. 5, 93–100 (2005).
   PubMed Web of Science ®Google Scholar
• Torabian S, Kashani-Sabet M. Biomarkers for melanoma. Curr. Opin. Oncol. 17, 167–171 (2005).
   PubMed Web of Science ®Google Scholar
• Ho L, Sharma N, Blackman L, Festa E, Reddy G, Pasinetti GM. From proteomics to biomarker discovery in Alzheimer’s disease. Brain Res. Brain Res. Rev. 48, 360–369 (2005).
   PubMed Web of Science ®Google Scholar
• Powell K. Proteomics delivers on promise of cancer biomarkers. Nature Med. 9, 980 (2003).
   PubMed Web of Science ®Google Scholar
• Verma M, Srivastava S. New cancer biomarkers deriving from NCI early detection research. Recent Results Cancer Res. 163, 72–84 (2003).
   PubMedGoogle Scholar
• Anderson NL. The roles of multiple proteomics platforms in a pipeline for new diagnostics. Mol. Cell. Proteomics 4(10), 1441–1444 (2005).
   Google Scholar
• Schweitzer B, Kingsmore SF. Measuring proteins on microarrays. Curr. Opin. Biotechnol. 13, 14–19 (2002).
   PubMed Web of Science ®Google Scholar
• Haab BB. Methods and applications of antibody microarrays in cancer research. Proteomics 3, 2116–2122 (2003).
   PubMed Web of Science ®Google Scholar
• Nielsen UB, Geierstanger BH. Multiplexed sandwich assays in microarray format. J. Immunol. Methods 290, 107–120 (2004).
   PubMed Web of Science ®Google Scholar
• Pavlickova P, Schneider EM, Hug H. Advances in recombinant antibody microarrays. Clin. Chim. Acta 343, 17–35 (2004).
   PubMed Web of Science ®Google Scholar
• Huang RP. Simultaneous detection of multiple proteins with an array-based enzyme-linked immunosorbent assay (ELISA) and enhanced chemiluminescence (ECL). Clin. Chem. Lab. Med. 39, 209–214 (2001).
   PubMed Web of Science ®Google Scholar
• Woodbury RL, Varnum SM, Zangar RC. Elevated HGF levels in sera from breast cancer patients detected using a protein microarray ELISA. J. Proteome Res. 1, 233–237 (2002).
   PubMed Web of Science ®Google Scholar
• Schweitzer B, Wiltshire S, Lambert J et al. Inaugural article: immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proc. Natl Acad. Sci. USA 97, 10113–10119 (2000).
   PubMed Web of Science ®Google Scholar
• Saviranta P, Okon R, Brinker A, Warashina M, Eppinger J, Geierstanger BH. Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime. Clin. Chem. 50, 1907–1920 (2004).
   PubMed Web of Science ®Google Scholar
• Liszewski K. Advances in protein arrays overcome obstacles. Genet. Eng. News 25, 40–43 (2005).
   Google Scholar
• Haab BB, Geierstanger BH, Michailidis G et al. Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics 5, 3278–3291 (2005).
   PubMed Web of Science ®Google Scholar
• Daly DS, White AM, Varnum SM, Anderson KK, Zangar RC. Evaluating concentration estimation errors in ELISA microarray experiments. BMC Bioinformatics 6, 17 (2005).
   PubMed Web of Science ®Google Scholar
• Conrad U, Scheller J. Considerations on antibody-phage display methodology. Comb. Chem. High Throughput. Screen. 8, 117–126 (2005).
   PubMed Web of Science ®Google Scholar
• Siegel RW, Coleman JR, Miller KD, Feldhaus MJ. High efficiency recovery and epitope-specific sorting of an scFv yeast display library. J. Immunol. Methods 286, 141–153 (2004).
   PubMed Web of Science ®Google Scholar
• Lopez MF, Pluskal MG. Protein micro- and macroarrays: digitizing the proteome. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 787, 19–27 (2003).
   PubMed Web of Science ®Google Scholar
• Wang XL, Li F, Su YH et al. Ultrasensitive detection of protein using an aptamer-based exonuclease protection assay. Anal. Chem. 77, 2278 (2005).
   Web of Science ®Google Scholar
• Shi L, Tong W, Goodsaid F et al. QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies. Expert Rev. Mol. Diagn. 4, 761–777 (2004).
   PubMed Web of Science ®Google Scholar
• Quackenbush J. Microarray data normalization and transformation. Nature Genet. 32(Suppl.), 496–501 (2002).
   PubMed Web of Science ®Google Scholar
• Kroll TC, Wolfl S. Ranking: a closer look on globalisation methods for normalisation of gene expression arrays. Nucleic Acids Res. 30, e50 (2002).
   PubMed Web of Science ®Google Scholar
• Grant GR, Manduchi E, Pizarro A, Stoeckert CJ Jr. Maintaining data integrity in microarray data management. Biotechnol. Bioeng. 84, 795–800 (2003).
   PubMed Web of Science ®Google Scholar
• Yang YH, Dudoit S, Luu P et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15 (2002).
   PubMed Web of Science ®Google Scholar
• Finkelstein D, Ewing R, Gollub J, Sterky F, Cherry JM, Somerville S. Microarray data quality analysis: lessons from the AFGC project. Arabidopsis Functional Genomics Consortium. Plant Mol. Biol. 48, 119–131 (2002).
   PubMed Web of Science ®Google Scholar
• Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J. Clin. 50, 7–33 (2000).
   PubMed Web of Science ®Google Scholar
• Lea JS, Miller DS. Optimum screening interventions for gynecologic malignancies. Tex. Med. 97, 49–55 (2001).
   PubMedGoogle Scholar